ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,574,000 | -36.2% | 381,089 | +25.2% | 0.00% | -33.3% |
| Q3 2016 | $2,466,000 | +72.0% | 304,452 | +65.6% | 0.00% | +200.0% |
| Q2 2016 | $1,434,000 | +77.9% | 183,836 | +76.1% | 0.00% | 0.0% |
| Q1 2016 | $806,000 | -20.6% | 104,397 | +11.0% | 0.00% | 0.0% |
| Q4 2015 | $1,015,000 | +72.0% | 94,077 | +10.2% | 0.00% | 0.0% |
| Q3 2015 | $590,000 | -31.5% | 85,370 | -12.2% | 0.00% | 0.0% |
| Q2 2015 | $861,000 | +26.4% | 97,217 | +40.7% | 0.00% | 0.0% |
| Q1 2015 | $681,000 | +7.1% | 69,115 | +33.2% | 0.00% | 0.0% |
| Q4 2014 | $636,000 | -72.6% | 51,879 | -77.7% | 0.00% | -50.0% |
| Q3 2014 | $2,321,000 | +133.0% | 232,588 | +76.7% | 0.00% | +100.0% |
| Q2 2014 | $996,000 | -25.1% | 131,633 | -67.4% | 0.00% | 0.0% |
| Q1 2014 | $1,330,000 | -36.9% | 404,207 | -36.4% | 0.00% | -50.0% |
| Q4 2013 | $2,109,000 | -0.3% | 635,534 | -9.3% | 0.00% | 0.0% |
| Q3 2013 | $2,116,000 | -78.0% | 700,677 | -40.5% | 0.00% | -80.0% |
| Q2 2013 | $9,637,000 | – | 1,178,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |